Premium
A high level of clinical response is associated with improved patient‐reported outcomes in psoriasis: analyses from a phase 2 study in patients treated with ixekizumab
Author(s) -
EdsonHeredia E.,
Banerjee S.,
Zhu B.,
MaedaChubachi T.,
Cameron G.S.,
Shen W.,
Heffernan M.P.,
Gordon K.B.,
Leonardi C.L.
Publication year - 2016
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.13032
Subject(s) - medicine , ixekizumab , library science , management , psoriasis , dermatology , computer science , secukinumab , psoriatic arthritis , economics